Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJarvis Securities Regulatory News (JIM)

Share Price Information for Jarvis Securities (JIM)

Share Price is delayed by 15 minutes
Get Live Data
9.00    0.00 (0.00%)
Bid:
8.00
Ask:
10.00
Spread: 2.00 (25.00%)
Market Cap: £4.03m
JIM Live PriceLast checked at - London Stock Exchange

Intraday Jarvis Securities Share Chart

Update on JIML

5 May 2026 07:00

RNS Number : 9084C
Jarvis Securities plc
05 May 2026
 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

Jarvis Securities plc

("Jarvis" or the "Company" and with its subsidiaries the "Group")

Update on JIML

On 7 July 2025 Jarvis announced (the "Announcement") that its wholly owned subsidiary Jarvis Investment Management Limited ("JIML") has sold its retail execution only brokerage business, (the "Transaction"). In order to deliver optimal value for shareholders, the Company has engaged S&W Partners LLP to explore the possibility of a sale of JIML. (the "Potential Disposal"). The Potential Disposal will be subject to conditions set out below and there can be no certainty as to the timing of the Potential Disposal or that it will occur at all.

After the Transaction, the termination of the Model B clearing and settlement services and the wind down of the associated operations (as further detailed in the Announcement) the assets presently remaining in JIML (which has permissions to undertake regulated activities and hold client assets) are:

i. approximately 1,800 clients with assets under administration of circa £44 million (including circa £7 million of potentially illiquid and/or non-returnable client assets), although this is declining as assets are withdrawn;

ii. the right to receive any deferred consideration due from the Transaction;

iii. any remaining cash balances; and 

iv. the group's intellectual property (which includes the "X-O" and "Sharedeal Active" trademarks).

 

It should be noted that any proposed sale of JIML's shares and any associated change of control would be subject to, the FCA's consent. 

Further updates will be provided in due course.

Steve Middleton, Non-executive Director of Jarvis Securities Plc, has approved this announcement and authorised its release.

Enquiries

Jarvis - C/O S&W Partners LLP - 0204 617 55 00 (Phil Hemming (Phil.hemming@swgroup.com) / Christopher Samson (Samson.christopher@swgroup.com))

 Zeus Capital (Nominated Adviser) - 020 3829 5000 (Katy Mitchell / Liv Highton)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDAKQBDFBKDAPK
Date   Source Headline
29th May 20262:10 pmRNSResult of GM
12th May 202611:55 amRNSNotice of GM
8th May 202611:57 amRNSConditional Property Sale, RPT & Proposed GM
5th May 20267:00 amRNSUpdate on JIML
30th Mar 20267:00 amRNSInterim Results
30th Jan 20267:00 amRNSResult of GM
27th Jan 20267:00 amRNSNon-Executive Director Appointment
15th Jan 20262:52 pmRNSHolding(s) in Company
30th Dec 20257:00 amRNSAudited Results, FCA Update & Notice of GM
30th Dec 20257:00 amRNSAudited Results, FCA Update & Notice of GM
23rd Dec 202511:47 amRNSHolding(s) in Company
23rd Dec 202511:47 amRNSHolding(s) in Company
23rd Dec 202511:25 amRNSHolding(s) in Company
23rd Dec 202511:25 amRNSHolding(s) in Company
23rd Dec 202511:09 amRNSBoard Change
23rd Dec 202511:09 amRNSBoard Change
19th Dec 20254:14 pmRNSHolding(s) in Company
19th Dec 20254:14 pmRNSHolding(s) in Company
19th Dec 20254:07 pmRNSResult of AGM
19th Dec 20254:07 pmRNSResult of AGM
11th Dec 20258:20 amRNSNotice of AGM
30th Sep 202510:20 amRNSAccounts Timetable Update
31st Jul 20254:30 pmRNSDividend Declaration and Company Update
7th Jul 20259:18 amRNSSale of Retail Execution-only Brokerage Business
27th Jun 20257:05 amRNSSecond Interim Results
27th Jun 20257:00 amRNSChange of Accounting Reference Date
15th Apr 20253:00 pmRNSSale of Retail Brokerage & Strategic Direction
20th Feb 20257:00 amRNSDividend Declaration
14th Nov 20247:00 amRNSDividend Declaration
25th Oct 202410:25 amRNSHolding(s) in Company
25th Oct 202410:24 amRNSHolding(s) in Company
25th Oct 202410:22 amRNSHolding(s) in Company
25th Oct 202410:19 amRNSHolding(s) in Company
23rd Oct 202412:41 pmRNSDirector / PMDR Shareholding
30th Aug 20245:08 pmRNSTR - 1
30th Aug 202412:02 pmRNSTR - 1
30th Aug 202412:00 pmRNSTR - 1
30th Aug 202412:00 pmRNSTR - 1
8th Aug 20247:01 amRNSDividend Declaration
8th Aug 20247:00 amRNSHalf-year Report
15th Jul 20247:00 amRNSChange of Nominated Adviser and Broker
27th Jun 20247:25 amRNSUpdate
9th May 20247:00 amRNSDIVIDEND DECLARATION
18th Apr 20244:20 pmRNSANNUAL GENERAL MEETING
18th Apr 20244:11 pmRNSProxy Votes
17th Apr 20244:15 pmRNSStrategic Update
26th Mar 20247:00 amRNSRESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
15th Feb 20247:00 amRNSDividend Declaration
13th Nov 202312:52 pmRNSDividend and Company Update
31st Oct 20232:35 pmRNSBoard Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.